SBRI Healthcare Competition – Stroke
07/08/2024
SBRI Healthcare – AMR
12/08/2024
£100k - £800k
Project Value
6 - 12 months
Project Length
28th August 2024
Competition Closes
The Women’s Health Strategy for England, The Scottish Women’s Health Plan, and the Women’s Health in Wales discovery report outline strong evidence of the need for a greater focus on women’s health, addressing the unique challenges women face across their lifespans, and to recognise and act on inequalities.
Under the overall theme of “Women’s Health”, Competition 25 Phase 1 invites early-stage innovations in the following three priority areas:
- Gynaecological Conditions and Hormonal Health
- Mental Health
- Chronic Conditions and Long-term Health
Fund details
The competition is open to any innovation (e.g., medical device, in-vitro diagnostic, digital health solutions and AI solutions, behavioural interventions, and service improvements) that meets the entry criteria and the challenges described in the Challenge brief.
Eligibility
Single organisations (contracts are executed with individual legal entities) based in the UK or EU from the private, public and third sectors, including companies (large corporates and small and medium enterprises), charities, universities, and NHS providers, given a strong commercial strategy is provided, are eligible to apply.
Organisations based outside the UK or EU with innovations in the remit for this call can apply as subcontractors of a lead UK/EU-based organisation or via a UK or EU subsidiary.
Collaborations are encouraged in the form of subcontracted services as appropriate.
At early stage, the SBRI Healthcare programme offers a two-phased development approach;
Phase 1 contracts for technical and commercial feasibility testing are valued at up to £100,000 (NET) and last for six months. If successful, Phase 1 projects are entitled to apply for Phase 2 contracts for prototype development and early clinical evidence which are usually worth up to £800,000 (NET) over 12 months, subject to budget availability.